Flexible Endoscopes Market (Product - Bronchoscopes, Laparoscopes, Laryngoscopes, Otoscopes, Ureteroscopes, Cystoscopes, Nasopharyngoscopes, Rhinoscopes, Arthroscopes, Neuroendoscopes, Hysteroscopes, Gynecology Endoscopes, and Gastrointestinal Endoscopes; End-use - Hospitals & Clinics, and Ambulatory Surgical Centers): Global Industry Analysis, Trends, Size, Share and Forecasts to 2032

Flexible Endoscopes Market (Product - Bronchoscopes, Laparoscopes, Laryngoscopes, Otoscopes, Ureteroscopes, Cystoscopes, Nasopharyngoscopes, Rhinoscopes, Arthroscopes, Neuroendoscopes, Hysteroscopes, Gynecology Endoscopes, and Gastrointestinal Endoscopes; End-use - Hospitals & Clinics, and Ambulatory Surgical Centers): Global Industry Analysis, Trends, Size, Share and Forecasts to 2032

Report Code: IGR01873 Category: Healthcare & Medical Devices Published: November, 2025

A recent report published by Infinium Global Research on flexible endoscopes market provides in-depth analysis of segments and sub-segments in the global as well as regional flexible endoscopes market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional flexible endoscopes market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global flexible endoscopes market.

Market Insight:

The global flexible endoscopes market was valued at USD 11.93 million in 2023 and is expected to reach USD 20.13 million in 2032, with a CAGR of 6.02% during the forecast period 2024-2032.

The flexible endoscopes market focuses on the development and distribution of endoscopic devices for diagnostic and therapeutic procedures. There is a shift towards single-use endoscopes to prevent cross-contamination, while advancements in AI-assisted diagnostics enhance real-time lesion detection. High-definition imaging and robot-assisted endoscopy improve diagnostic precision and maneuverability. Key players are innovating products, focusing on AI integration, and forming strategic partnerships to enhance R&D and distribution. Challenges include complex sterilization and regulatory hurdles, which can be addressed through cost-effective manufacturing and collaboration with regulatory bodies to streamline approvals.

The growth of the flexible endoscopes market is driven by the rising prevalence of chronic diseases like cancer and cardiovascular conditions, increasing the demand for accurate, minimally invasive diagnostic procedures. These endoscopes allow for early detection and better visualization of internal organs, improving patient outcomes and recovery times. The aging population also contributes to the need for regular diagnostic monitoring, prompting healthcare systems to adopt flexible endoscopes. Investment in healthcare infrastructure in both emerging and developed regions further supports this growth, with budget allocations aimed at enhancing diagnostic capabilities and patient care. However, high production and operational costs pose challenges, particularly in low- and middle-income countries. Nonetheless, the integration of AI-enabled endoscopy systems is set to create significant market opportunities by improving diagnostic accuracy and workflow efficiency. Companies like Fujifilm, Pentax, and Olympus are already incorporating AI tools, positioning themselves to capture high-margin segments as regulatory standards evolve and clinical acceptance increases.

Product Insight

The gastrointestinal endoscopes segment dominated the product segment of the global flexible endoscopes market with more than 54% revenue share, driven by the rising prevalence of gastrointestinal disorders like colorectal cancer and inflammatory bowel disease, which require regular diagnostics. The American Cancer Society projected around 26,500 new stomach cancer cases in 2023, underscoring the demand for endoscopes. Additionally, the increasing awareness of flexible gastroscopes and ongoing research will further boost market growth. The laparoscopes segment is expected to grow the fastest, thanks to the rising need for procedures addressing obesity and gastrointestinal issues. Investments in technology have enhanced imaging and functionality, making these devices more attractive and cost-effective compared to traditional instruments. For example, in April 2023, Xenocor secured USD 10 million in Series A funding.

End-use Insight

The hospitals segment led the market with a revenue share of more than 63% due to favorable reimbursement, a high number of endoscopic procedures, and a preference for minimally invasive techniques. The shift towards single-use endoscopes in hospitals to minimize infection and technological advancements in flexible endoscopes further drive growth. The number of hospitals is increasing globally, with 6,120 in the U.S. and around 15,000 in the EU. Meanwhile, outpatient facilities are expected to grow at the fastest rate due to their accessibility, cost-effectiveness, and government initiatives to improve healthcare infrastructure.

Regional Insight

The global flexible endoscopes market is divided into North America, Europe, the Asia Pacific, and the Rest of the World. North America leads in market share due to its advanced healthcare infrastructure, high adoption of minimally invasive procedures, favorable reimbursement policies, and a growing elderly population that increases the need for endoscopic diagnoses. Investments in research and development have also introduced advanced, AI-integrated flexible endoscopes. Moreover, the Asia-Pacific region is projected to experience the highest growth rate, driven by rapid healthcare infrastructure development, rising awareness of early disease detection, and increased healthcare spending in countries such as India and China. The growing geriatric population and a rise in gastrointestinal and pulmonary conditions are driving demand for these diagnostic tools, supported by government initiatives, medical tourism, and cost-effective local manufacturing.

Recent Developments

In May 2025, FUJIFILM Healthcare Europe announced the launch of the new therapeutic gastroscopes ELUXEO® EG-840T and the specially designed narrow EG-840TP endoscope for advanced treatments in Europe. This follows the groundbreaking ELUXEO® 8000 system.

In August 2024, KARL STORZ USA and FUJIFILM Healthcare Americas Corporation formed a strategic partnership to deliver comprehensive solutions for endoscopists and surgeons.

In April 2024, Olympus received U.S. FDA 510(k) clearance for RenaFlex, its first single-use flexible ureteroscope system. Designed to diagnose and treat urinary diseases like kidney stones, the RenaFlex system visualizes the urinary tract (urethra, bladder, ureter, calyces, and renal papillae) through transurethral or percutaneous access. It can be used with endotherapeutic accessories for diagnostic and therapeutic procedures.

Report Scope of the Flexible Endoscopes Market:

Report Coverage Details
Market Size in 2023 USD 11.93 Billion
Market Size by 2032 USD 20.13 Billion
Growth Rate from 2024 to 2032 CAGR of 6.02%
Largest Market North America
No. of Pages 180
Market Drivers
  • The rising prevalence of chronic diseases is propelling the market expansion.

  • Expanding healthcare infrastructure is fostering market expansion.

Market Segmentation By Product, and By End-use
Regional Scope North America, Europe, Asia Pacific, and RoW

Segment wise revenue contribution in the global flexible endoscopes market

The report on global flexible endoscopes market provides a detailed analysis of segments in the market based on Product, and End-use.

Segmentation Based on Product

·       Bronchoscopes

·       Laparoscopes

·       Laryngoscopes

·       Otoscopes

·       Ureteroscopes

·       Cystoscopes

·       Nasopharyngoscopes

·       Rhinoscopes

·       Arthroscopes

·       Neuroendoscopes

·       Hysteroscopes

·       Gynecology Endoscopes

·       Gastrointestinal Endoscopes

Segmentation Based on End-use

·       Hospitals & Clinics

·       Ambulatory Surgical Centers

Company Profiled:

·       Olympus

·       KARL STORZ SE & Co. KG

·       FUJIFILM Corporation

·       Stryker

·       Boston Scientific Corporation

·       Richard Wolf GmbH

·       Medtronic

·       Hoya Corporation

·       EndoMed Systems GmbH

·       Optim LLC

Report Highlights:

The report provides deep insights into demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the flexible endoscopes market. Moreover, the study highlights current market trends and provides forecasts from 2024-2032. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Frequently Asked Questions (FAQ's)

The global flexible endoscopes market was valued at USD 11.93 Billion in 2023.
It is likely to grow at a CAGR of 6.02% during the forecast period 2024-2032.
The global flexible endoscopes market is estimated to reach USD 20.13 Billion by the end of 2032.
North America is anticipated to exhibit high demand for flexible endoscopes market during the forecast period.
Olympus, KARL STORZ SE & Co. KG, FUJIFILM Corporation, Stryker, Boston Scientific Corporation, Richard Wolf GmbH, Medtronic, Hoya Corporation, EndoMed Systems GmbH, and Optim LLC.
© 2024. Infinium Global Research LLP. All Rights Reserved.